de Lima Ramos P A, Martín-Comin J, Muñoz A, Baliellas C, Vilar L, Roca M, Ramos M
Becario del Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brasil.
Med Clin (Barc). 1998 Sep 12;111(7):241-6.
The 99mTc-exametazine labelled leukocytes (99mTc-WBC) scintigraphy is an established method for the inflammatory bowel disease (IBD) diagnosis, but the labelled procedure is a large and laborious process. The 111In-labelled human polyclonal immunoglobulin G (111In-IgG) can be an alternative in the non invasive IBD diagnosis.
Thirty-four patients routinely referred for investigation of IBD were studied. The 99mTc-WBC and 111In-IgG were simultaneously injected and images were obtained at 30 min, 3 and 24 h post-injection. The diagnostic was established by histology of endoscopy and/or surgery samples. Images were blindly evaluated by two experienced observers who only knew of the clinical suspicion of IBD. IBD was confirmed in 27 patients (17 with Crohn's disease [CD] and 10 with ulcerative colitis [UC]).
Sensitivity, specificity and accuracy were 88.5, 100 and 90.3% respectively for endoscopy, 73.7, 75 and 73.9% for radiology, 59.3, 85.7 and 64.7% for 111In-IgG scan and 96.3, 85.7 and 94.1% for 99mTc-WBC scan. In the diagnosis of CD involvement of small bowel, the 99mTc-WBC scan identified 9/11 patients with confirmed disease, whereas the 111In-IgG scan diagnosed only four of them. In the evaluation of colonic disease, the 99mTc-WBC scan correctly diagnosed 21/22 confirmed patients, being the 111In-IgG scan positive in 13 of them. As far as disease extension concerned, the 99mTc-WBC demonstrated a statistically significance rather number of disease segments than endoscopy, radiology and 111In-IgG scan.
The 99mTc-WBC was an effective method in the diagnosis of suspected IBD patients, both in the evaluation of small bowel disease and colonic disease, with slightly best results for colonic disease, whereas the 111In-IgG scan seems to have no utility neither in diagnosis nor in extension evaluation of IBD.
99mTc-依克沙美嗪标记白细胞(99mTc-WBC)闪烁扫描术是诊断炎症性肠病(IBD)的一种成熟方法,但标记过程繁琐且耗时。111In标记的人多克隆免疫球蛋白G(111In-IgG)可作为IBD无创诊断的替代方法。
对34例常规转诊进行IBD检查的患者进行研究。同时注射99mTc-WBC和111In-IgG,并在注射后30分钟、3小时和24小时获取图像。通过内镜检查和/或手术样本的组织学检查确诊。由两名仅知晓临床怀疑IBD的经验丰富的观察者对图像进行盲法评估。27例患者确诊为IBD(17例克罗恩病[CD],10例溃疡性结肠炎[UC])。
内镜检查的敏感性、特异性和准确性分别为88.5%、100%和90.3%,放射学检查分别为73.7%、75%和73.9%,111In-IgG扫描分别为59.3%、85.7%和64.7%,99mTc-WBC扫描分别为96.3%、85.7%和94.1%。在诊断小肠CD受累方面,99mTc-WBC扫描识别出9/11例确诊患者,而111In-IgG扫描仅诊断出其中4例。在评估结肠疾病时,99mTc-WBC扫描正确诊断出21/22例确诊患者,其中111In-IgG扫描有13例呈阳性。就疾病范围而言,99mTc-WBC显示出的病变节段数量在统计学上比内镜检查、放射学检查和111In-IgG扫描更多。
99mTc-WBC是诊断疑似IBD患者的有效方法,在评估小肠疾病和结肠疾病方面均有效,对结肠疾病的诊断效果略佳,而1 In-IgG扫描在IBD的诊断和范围评估中似乎均无用处。